体积 1, 问题 8 (2011)
评论文章
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
评论文章
Impact of recent landmark clinical trials on hypertension treatment
Ikechi G Okpechi, Brian L Rayner
评论文章
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
评论文章
Triple-negative breast cancer and new treatment developments
Stephen Dyar, Alvaro Moreno-Aspitia
评论文章
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
评论文章
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
治疗前景
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
